{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:24:46Z","timestamp":1780097086791,"version":"3.54.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003810","name":"Hospital de Cl\u00ednicas de Porto Alegre","doi-asserted-by":"publisher","award":["FIPE-HCPA 340\/2004"],"award-info":[{"award-number":["FIPE-HCPA 340\/2004"]}],"id":[{"id":"10.13039\/501100003810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["1289\/05"],"award-info":[{"award-number":["1289\/05"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["INCT 573747\/2008-3"],"award-info":[{"award-number":["INCT 573747\/2008-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.steroids.2011.07.008","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T00:43:42Z","timestamp":1311641022000},"page":"1383-1388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"76","author":[{"given":"Sheila B.","family":"Lecke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora M.","family":"Morsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poli M.","family":"Spritzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2011.07.008_b0005","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.07.008_b0010","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2011.07.008_b0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.07.008_b0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.07.008_b0025","doi-asserted-by":"crossref","first-page":"758656","DOI":"10.1155\/2010\/758656","article-title":"Mediators of inflammation in polycystic ovary syndrome in relation to adiposity","volume":"2010","author":"Sathyapalan","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.steroids.2011.07.008_b0030","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.fertnstert.2010.02.015","article-title":"Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes","volume":"94","author":"Wiltgen","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2011.07.008_b0035","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.07.008_b0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1590\/S0004-27302007000100024","article-title":"Prevalence of metabolic syndrome in patients of south of Brazil with polycystic ovary syndrome (PCOS)","volume":"51","author":"Spritzer","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.steroids.2011.07.008_b0045","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1210\/jc.2004-0934","article-title":"Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome","volume":"89","author":"Yildiz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.07.008_b0050","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1210\/jc.2008-0288","article-title":"Do cardiovascular risk factors in polycystic ovarian syndrome result in more cardiovascular events?","volume":"93","author":"Guzick","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.07.008_b0055","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2009.04.021","article-title":"Not all women diagnosed with PCOS share the same cardiovascular risk profiles","volume":"94","author":"Jovanovic","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2011.07.008_b0060","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.fertnstert.2008.09.070","article-title":"Long-term consequences of polycystic ovary syndrome on cardiovascular risk","volume":"91","author":"Rizzo","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2011.07.008_b0065","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.07.008_b0070","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1152\/ajpendo.00039.2008","article-title":"Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis","volume":"296","author":"Blouin","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.07.008_b0075","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/153537020122601106","article-title":"Adipocyte differentiation: from fibroblast to endocrine cell","volume":"226","author":"Gregoire","year":"2001","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.steroids.2011.07.008_b0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.physiol.64.081601.142703","article-title":"Aromatase \u2013 a brief overview","volume":"64","author":"Simpson","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.steroids.2011.07.008_b0085","first-page":"321","article-title":"Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence","volume":"72","author":"Belgorosky","year":"2009","journal-title":"Horm Res"},{"key":"10.1016\/j.steroids.2011.07.008_b0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/er.2008-0016","article-title":"History of aromatase: saga of an important biological mediator and therapeutic target","volume":"30","author":"Santen","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.steroids.2011.07.008_b0095","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1097\/01.hjh.0000188728.66183.92","article-title":"Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study","volume":"23","author":"Peter","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.steroids.2011.07.008_b0100","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/HYPERTENSIONAHA.107.096263","article-title":"Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants","volume":"50","author":"Ramirez-Lorca","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2011.07.008_b0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7150\/ijms.5.29","article-title":"Association study of aromatase gene (CYP19A1) in essential hypertension","volume":"5","author":"Shimodaira","year":"2008","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.steroids.2011.07.008_b0110","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1097\/01.all.0000191242.73997.5b","article-title":"Estrogen-related genes and blood pressure: an example of the complexity of advanced association studies","volume":"23","author":"Yagil","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.steroids.2011.07.008_b0115","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41\u20137.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.steroids.2011.07.008_b0120","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2011.07.008_b0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejogrb.2006.09.009","article-title":"Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity","volume":"133","author":"Nacul","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.steroids.2011.07.008_b0130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2265.2000.00982.x","article-title":"Spironolactone as a single agent for long-term therapy of hirsute patients","volume":"52","author":"Spritzer","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.steroids.2011.07.008_b0135","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/humrep\/16.7.1340","article-title":"Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements","volume":"16","author":"Spritzer","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.steroids.2011.07.008_b0140","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.metabol.2007.03.006","article-title":"Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome","volume":"56","author":"Toscani","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.steroids.2011.07.008_b0145","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/humrep\/dep072","article-title":"Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome","volume":"24","author":"Wiltgen","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.steroids.2011.07.008_b0150","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.07.008_b0155","doi-asserted-by":"crossref","unstructured":"NCEP. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1016\/j.steroids.2011.07.008_b0160","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.gme.0000177907.32634.ae","article-title":"Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio","volume":"13","author":"Donato","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.steroids.2011.07.008_b0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.steroids.2011.07.008_b0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10735-009-9212-7","article-title":"C-fos gene and protein expression in pelvic endometriosis: a local marker of estrogen action","volume":"40","author":"Morsch","year":"2009","journal-title":"J Mol Histol"},{"key":"10.1016\/j.steroids.2011.07.008_b0175","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0039-128X(03)00093-X","article-title":"Gene expression of type 2 17 beta hydroxysteroid dehydrogenase in scalp hairs of hirsute women","volume":"68","author":"Oliveira","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2011.07.008_b0180","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt0492-413","article-title":"Simultaneous amplification and detection of specific DNA sequences","volume":"10","author":"Higuchi","year":"1992","journal-title":"Biotechnology (NY)"},{"key":"10.1016\/j.steroids.2011.07.008_b0185","first-page":"1026","article-title":"Kinetic PCR analysis: real-time monitoring of DNA amplification reactions","volume":"11","author":"Higuchi","year":"1993","journal-title":"Biotechnology (NY)"},{"key":"10.1016\/j.steroids.2011.07.008_b0190","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/nar\/gnh101","article-title":"Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications","volume":"32","author":"Zipper","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.steroids.2011.07.008_b0195","unstructured":"Applied Biosystems. Relative quantitation of gene expression experimental design and analysis: relative standard curve method and comparative Ct method (\u0394\u0394Ct). Guide to performing relative quantitation of gene expression using real-time quantitative PCR. Foster City: Apllied Byosystems; 2004. p. 34\u201349."},{"key":"10.1016\/j.steroids.2011.07.008_b0200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.steroids.2011.07.008_b0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2169\/internalmedicine.41.64","article-title":"Insulin resistance and hypertension in adolescents and adults","volume":"41","author":"Saito","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.steroids.2011.07.008_b0210","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","volume":"93","author":"Shaw","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.07.008_b0215","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2337\/diacare.29.03.06.dc05-0970","article-title":"Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin resistance","volume":"29","author":"Sierra-Johnson","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.steroids.2011.07.008_b0220","first-page":"126","article-title":"Aromatase research and its clinical significance","volume":"61","author":"Czajka-Oraniec","year":"2010","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.steroids.2011.07.008_b0225","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.RES.84.11.1285","article-title":"Localized expression of aromatase in human vascular tissues","volume":"84","author":"Harada","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.steroids.2011.07.008_b0230","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","article-title":"Sources of estrogen and their importance","volume":"86","author":"Simpson","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.07.008_b0235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.diabet.2007.09.004","article-title":"Adipokines: the missing link between insulin resistance and obesity","volume":"34","author":"Antuna-Puente","year":"2008","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.steroids.2011.07.008_b0240","doi-asserted-by":"crossref","first-page":"E631","DOI":"10.1152\/ajpendo.00467.2005","article-title":"Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization","volume":"291","author":"Spratt","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.07.008_b0245","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jsbmb.2007.05.027","article-title":"Aromatase excess in cancers of breast, endometrium and ovary","volume":"106","author":"Bulun","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.07.008_b0250","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1467-789X.2009.00592.x","article-title":"Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives","volume":"10","author":"Maccio","year":"2009","journal-title":"Obes Rev"},{"key":"10.1016\/j.steroids.2011.07.008_b0255","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/jhh.2009.1","article-title":"Association between arterial stiffness and variations in oestrogen-related genes","volume":"23","author":"Peter","year":"2009","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.steroids.2011.07.008_b0260","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1210\/jc.2010-1123","article-title":"Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism","volume":"95","author":"Legro","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11002467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11002467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:03:13Z","timestamp":1758535393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X11002467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0039128X11002467"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2011.07.008","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2011.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}